Human mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells or
medicinal signaling cells, are important adult stem cells for regenerative medicine, largely …

It was shown as long as half a century ago that bone marrow is a source of not only
hematopoietic stem cells, but also stem cells of mesenchymal tissues. Then the term …

Mesenchymal stromal cells (MSCs), present in the stromal component of several tissues,
include multipotent stem cells, progenitors, and differentiated cells. MSCs have quickly …

Mesenchymal stem cells (MSCs) are multipotent cells that represent a promising source for
regenerative medicine. MSCs are capable of osteogenic, chondrogenic, adipogenic and …

Multiwalled carbon nanotubes (MWCNTs) have the potential for widespread applications in
engineering and materials science. However, because of their needle-like shape and high …

The term mesenchymal stem cell (MSCs) was adopted in the 1990s to describe a population
of bone‐marrow‐derived cells that demonstrated the capacity for tri‐lineage differentiation at …

The identification of multipotential mesenchymal stem cells (MSCs) derived from adult
human tissues, including bone marrow stroma and a number of connective tissues, has …

Alternative pre-mRNA splicing is a highly cell type–specific process essential to generating
protein diversity. However, the mechanisms responsible for the establishment and …

In regenerative medicine, bone marrow is a promising source of mesenchymal stem cells
(MSCs) for a broad range of cellular therapies. This research addresses a basic prerequisite …

The premature-ageing disease Hutchinson-Gilford Progeria Syndrome (HGPS) is caused by
constitutive production of progerin, a mutant form of the nuclear architectural protein lamin …